Cohance Lifesciences Limited (NSE:COHANCE)

India · Delayed Price · Currency is INR

425.25

-0.05 (-0.01%)

Jul 31, 2026, 3:30 PM IST

Cohance Lifesciences Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	22,686	22,686	26,085	10,514	13,403	13,202
Revenue Growth	-13.03%	-13.03%	148.11%	-21.56%	1.52%	30.75%
Gross Profit	16,059	16,059	17,920	6,797	7,521	7,461
Operating Income	2,397	2,397	6,303	3,544	5,262	5,416
Net Income	1,792	1,792	4,873	3,003	4,113	4,538
Earnings Per Share	4.68	4.68	12.68	11.80	16.16	17.83
EPS Growth	-63.09%	-63.09%	7.50%	-26.99%	-9.37%	25.27%

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	3,260	3,260	2,942	8,211	4,837	5,258
Total Debt	4,005	4,005	4,859	650.1	703.41	971.27
Net Cash (Debt)	-745.1	-745.1	-1,917	7,561	4,134	4,287
Net Cash Growth	-	-	-	82.90%	-3.56%	858.10%
Net Cash Per Share	-1.95	-1.95	-4.99	29.70	16.24	16.84

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	3,683	3,683	6,734	3,848	4,572	3,300
Capital Expenditures	-2,199	-2,199	-3,168	-518.8	-2,859	-751.87
Free Cash Flow	1,484	1,484	3,566	3,329	1,713	2,548
Free Cash Flow Growth	-58.37%	-58.37%	7.11%	94.35%	-32.78%	-6.21%

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	70.79%	70.79%	68.70%	64.65%	56.11%	56.51%
Operating Margin	10.56%	10.56%	24.16%	33.71%	39.26%	41.02%
Pretax Margin	9.13%	9.13%	24.64%	38.59%	41.76%	50.57%
Profit Margin	7.90%	7.90%	18.68%	28.56%	30.69%	34.37%
FCF Margin	6.54%	6.54%	13.67%	31.66%	12.78%	19.30%

Dividends

Fiscal Year	FY 2023	FY 2022
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Dividend Per Share	3.000	2.000
Dividend Per Share Growth	50.00%	0%
Dividend Yield	0.64%	0.33%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	90.82	64.35	60.12	57.40	29.24	34.69
Forward PE	59.32	39.98	63.44	44.40	26.23	30.48
P/FCF Ratio	109.55	77.69	82.18	51.78	70.21	61.79
PS Ratio	7.17	5.08	11.23	16.40	8.97	11.93